We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+43.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.75B
AUM Growth
+$811M
Cap. Flow
+$363M
Cap. Flow %
13.21%
Top 10 Hldgs %
44.65%
Holding
241
New
88
Increased
39
Reduced
33
Closed
64

Top Buys

Rank Stock Value
1
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
+$36.2M
2
HYFM icon
Hydrofarm Holdings
HYFM
+$19.6M
3
LUNG icon
Pulmonx
LUNG
+$19.2M
4
SEER icon
Seer Inc
SEER
+$18.7M
5
ABCL icon
AbCellera Biologics
ABCL
+$16.7M

Top Sells

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$27M
2
INSP icon
Inspire Medical Systems
INSP
+$11.3M
3
PPD
PPD, Inc. Common Stock
PPD
+$11.1M
4
STAA icon
STAAR Surgical
STAA
+$10.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$9.3M

Sector Composition

Rank Sector Weight
1 Healthcare 34.42%
2 Industrials 1.65%
3 Consumer Staples 0.32%
4 Financials 0.08%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BFLY icon
101
Butterfly Network
BFLY
$2.52B
$5.64M 0.21%
+285,000
New +$3.65M
IMVT icon
102
Immunovant
IMVT
$8.8B
$5.48M 0.2%
118,702
-40,324
-25% -$1.86M
AXNX
103
PUT
DELISTED
Axonics, Inc. Common Stock
AXNX
$4.99M 0.18%
+100,000
New +$4.7M
CMPS
104
Compass Pathways
CMPS
$1.97B
$4.91M 0.18%
102,994
-12,500
-11% -$533K
RGEN icon
105
Repligen
RGEN
$9.35B
$4.79M 0.17%
+25,000
New +$4.55M
TELA icon
106
TELA Bio
TELA
$32.3M
$4.65M 0.17%
309,323
+20,718
+7% +$336K
ZBH icon
107
CALL
Zimmer Biomet
ZBH
$18.7B
$4.62M 0.17%
30,900
– –
STXS icon
108
Stereotaxis
STXS
$139M
$4.59M 0.17%
902,275
– –
CRIS icon
109
Curis
CRIS
$3.49M
$4.54M 0.17%
1,386
+886
+177% +$1.06M
HA
110
CALL
DELISTED
Hawaiian Holdings, Inc.
HA
$4.42M 0.16%
+250,000
New +$4.23M
SNCE
111
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$4.27M 0.16%
+20,000
New +$4.16M
IMGN
112
DELISTED
Immunogen Inc
IMGN
$3.97M 0.14%
+615,286
New +$3.59M
QGEN icon
113
PUT
Qiagen
QGEN
$8.88B
$3.96M 0.14%
+70,729
New +$3.77M
GTH
114
DELISTED
Genetron Holdings Limited ADS
GTH
$3.74M 0.14%
+88,967
New +$3.23M
BGMS
115
Bio Green Med Solution Inc
BGMS
$5.1M
$3.71M 0.13%
+132
New +$2.02M
CNCE
116
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$3.71M 0.13%
+293,443
New +$3.34M
PEN icon
117
PUT
Penumbra
PEN
$12.9B
$3.5M 0.13%
+20,000
New +$4.38M
KRA
118
CALL
DELISTED
Kraton Corporation
KRA
$3.47M 0.13%
+125,000
New +$3.38M
LGVW.WS
119
DELISTED
Longview Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Clas
LGVW.WS
$3.46M 0.13%
+525,000
New +$1.33M
NKTR icon
120
CALL
Nektar Therapeutics
NKTR
$2.57B
$3.4M 0.12%
+13,333
New +$3.45M
TRIL
121
DELISTED
Trillium Therapeutics Inc.
TRIL
$3.15M 0.11%
214,487
-100,000
-32% -$1.44M
BCRX icon
122
BioCryst Pharmaceuticals
BCRX
$2.71B
$3.07M 0.11%
412,419
-309,500
-43% -$1.6M
LH icon
123
PUT
Labcorp
LH
$26.2B
$3.05M 0.11%
+17,460
New +$3.02M
MIST icon
124
Milestone Pharmaceuticals
MIST
$141M
$3.02M 0.11%
450,000
+350,000
+350% +$2.34M
VINC
125
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$3.01M 0.11%
+7,201
New +$2.27M
3 4
5
6 7

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2020 Portfolio in Review

As of Q4 2020, Pura Vida Investments held 241 positions worth $2.75B, up 42% from $1.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Pura Vida Investments deployed $363M of net new capital in Q4 2020, opening 88 new positions and adding to 39 existing holdings. Its largest new stake was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Inspire Medical Systems, an estimated $11.3M trimmed.

  • Pura Vida Investments's largest Q4 2020 buy was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.
  • Pura Vida Investments added most to Guardant Health in Q4 2020, an estimated $9.2M increase.
  • Pura Vida Investments's biggest Q4 2020 reduction was Inspire Medical Systems, cutting an estimated $11.3M.
  • Pura Vida Investments fully exited Cooper Companies in Q4 2020, selling an estimated $27M.
  • Pura Vida Investments's ten largest holdings make up 45% of its $2.75B portfolio in Q4 2020.
  • Pura Vida Investments opened 88 new positions and closed 64 in Q4 2020.
  • Pura Vida Investments's portfolio value rose 42% quarter-over-quarter to $2.75B.

Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.